Drug Profile
Research programme: artemisinin derived compounds - Artemisia BioMedical
Alternative Names: ART Dimer; ART Dimer-Iron Chelator; ART Dimer-PeptideLatest Information Update: 13 Jul 2016
Price :
$50
*
At a glance
- Originator Artemisia BioMedical
- Class Antimalarials; Antineoplastics; Artemisinins
- Mechanism of Action Carrier protein inhibitors; Immunomodulators; Mitochondrial protein inhibitors; Protein synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes - Cancer; Inflammation; Malaria
Highest Development Phases
- Discontinued Cancer; Inflammation; Malaria
Most Recent Events
- 13 Jul 2016 Discontinued - Preclinical for Cancer in USA (unspecified route)
- 13 Jul 2016 Discontinued - Preclinical for Malaria in USA (unspecified route)
- 13 Jul 2016 Discontinued for Inflammation in USA (unspecified route)